Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervertebral Disc REgeneration mediated by Autologous Mesenchymal stem/stromal cells intradiscal injection
2024-519112-14-00Phase 2Completed
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Feb 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous bone marrow-derived mesenchymal stem/stromal cells in lumbodynia (LBP) and degenerative disc disease (DDD), sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Started Feb 2025; status: completed.
02
Drugs
autologous bone marrow-derived mesenchymal stem/stromal cells
03
Conditions
lumbodynia (LBP)degenerative disc disease (DDD)
Beyond the preview
Go deeper on 2024-519112-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519112-14-00.